REIT - Industrial
Compare Stocks
4 / 10Stock Comparison
NHPAP vs CTRE vs SBRA vs NHI
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Healthcare Facilities
NHPAP vs CTRE vs SBRA vs NHI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | REIT - Industrial | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $592M | $8.82B | $5.19B | $3.64B |
| Revenue (TTM) | $348M | $468M | $813M | $403M |
| Net Income (TTM) | $-80M | $335M | $156M | $148M |
| Gross Margin | 36.2% | 86.8% | 63.5% | 61.3% |
| Operating Margin | -4.2% | 69.1% | 29.0% | 48.5% |
| Forward P/E | — | 26.6x | 29.8x | 22.2x |
| Total Debt | $1.15B | $894M | $2.55B | $1.16B |
| Cash & Equiv. | $22M | $198M | $72M | $20M |
NHPAP vs CTRE vs SBRA vs NHI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| National Healthcare… (NHPAP) | 100 | 114.8 | +14.8% |
| CareTrust REIT, Inc. (CTRE) | 100 | 212.1 | +112.1% |
| Sabra Health Care R… (SBRA) | 100 | 152.9 | +52.9% |
| National Health Inv… (NHI) | 100 | 135.3 | +35.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NHPAP vs CTRE vs SBRA vs NHI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NHPAP is the #2 pick in this set and the best alternative if momentum is your priority.
- +60.6% vs NHI's +2.8%
CTRE carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.14, yield 3.2%
- Rev growth 108.8%, EPS growth 96.3%, 3Y rev CAGR 36.5%
- 265.1% 10Y total return vs NHI's 58.9%
- Lower volatility, beta 0.14, Low D/E 22.1%, current ratio 1.54x
SBRA lags the leaders in this set but could rank higher in a more targeted comparison.
NHI is the clearest fit if your priority is value.
- Lower P/E (22.2x vs 26.6x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 108.8% FFO/revenue growth vs NHPAP's 2.3% | |
| Value | Lower P/E (22.2x vs 26.6x) | |
| Quality / Margins | 71.5% margin vs NHPAP's -23.0% | |
| Stability / Safety | Beta 0.14 vs NHPAP's 0.17, lower leverage | |
| Dividends | 3.2% yield, 2-year raise streak, vs SBRA's 5.8% | |
| Momentum (1Y) | +60.6% vs NHI's +2.8% | |
| Efficiency (ROA) | 6.7% ROA vs NHPAP's -4.6%, ROIC 6.1% vs -4.8% |
NHPAP vs CTRE vs SBRA vs NHI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NHPAP vs CTRE vs SBRA vs NHI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CTRE leads in 3 of 6 categories
NHPAP leads 1 • SBRA leads 0 • NHI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CTRE leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SBRA is the larger business by revenue, generating $813M annually — 2.3x NHPAP's $348M. CTRE is the more profitable business, keeping 71.5% of every revenue dollar as net income compared to NHPAP's -23.0%. On growth, CTRE holds the edge at +99.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $348M | $468M | $813M | $403M |
| EBITDAEarnings before interest/tax | $72M | $428M | $432M | $282M |
| Net IncomeAfter-tax profit | -$80M | $335M | $156M | $148M |
| Free Cash FlowCash after capex | -$125M | $400M | $367M | $226M |
| Gross MarginGross profit ÷ Revenue | +36.2% | +86.8% | +63.5% | +61.3% |
| Operating MarginEBIT ÷ Revenue | -4.2% | +69.1% | +29.0% | +48.5% |
| Net MarginNet income ÷ Revenue | -23.0% | +71.5% | +19.2% | +36.8% |
| FCF MarginFCF ÷ Revenue | -35.9% | +85.5% | +45.1% | +56.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.9% | +99.3% | +20.8% | +29.7% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +2.9% | -5.9% | +10.8% |
Valuation Metrics
NHPAP leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 24.9x trailing earnings, NHI trades at a 23% valuation discount to SBRA's 32.2x P/E. On an enterprise value basis, SBRA's 17.0x EV/EBITDA is more attractive than CTRE's 23.0x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $592M | $8.8B | $5.2B | $3.6B |
| Enterprise ValueMkt cap + debt − cash | $1.7B | $9.5B | $7.7B | $4.8B |
| Trailing P/EPrice ÷ TTM EPS | -2.91x | 25.17x | 32.16x | 24.85x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 26.58x | 29.83x | 22.17x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.19x | — | — |
| EV / EBITDAEnterprise value multiple | — | 23.03x | 17.01x | 17.16x |
| Price / SalesMarket cap ÷ Revenue | 1.67x | 18.51x | 6.70x | 9.61x |
| Price / BookPrice ÷ Book value/share | 0.86x | 2.00x | 1.78x | 2.29x |
| Price / FCFMarket cap ÷ FCF | — | 23.27x | 14.89x | 16.52x |
Profitability & Efficiency
CTRE leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
NHI delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-12 for NHPAP. CTRE carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to NHPAP's 1.67x. On the Piotroski fundamental quality scale (0–9), NHI scores 6/9 vs NHPAP's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -12.3% | +8.6% | +5.6% | +9.8% |
| ROA (TTM)Return on assets | -4.6% | +6.7% | +2.8% | +5.4% |
| ROICReturn on invested capital | -4.8% | +6.1% | +3.8% | +5.6% |
| ROCEReturn on capital employed | -7.7% | +7.7% | +5.2% | +8.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 5 | 6 |
| Debt / EquityFinancial leverage | 1.67x | 0.22x | 0.90x | 0.76x |
| Net DebtTotal debt minus cash | $1.1B | $696M | $2.5B | $1.1B |
| Cash & Equiv.Liquid assets | $22M | $198M | $72M | $20M |
| Total DebtShort + long-term debt | $1.1B | $894M | $2.6B | $1.2B |
| Interest CoverageEBIT ÷ Interest expense | -1.78x | 8.44x | 2.40x | 3.45x |
Total Returns (Dividends Reinvested)
CTRE leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTRE five years ago would be worth $19,660 today (with dividends reinvested), compared to $12,266 for NHPAP. Over the past 12 months, NHPAP leads with a +60.6% total return vs NHI's +2.8%. The 3-year compound annual growth rate (CAGR) favors CTRE at 29.6% vs NHPAP's 12.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +18.1% | +9.9% | +9.0% | -1.1% |
| 1-Year ReturnPast 12 months | +60.6% | +40.3% | +20.5% | +2.8% |
| 3-Year ReturnCumulative with dividends | +42.0% | +117.8% | +113.0% | +73.5% |
| 5-Year ReturnCumulative with dividends | +22.7% | +96.6% | +49.9% | +31.0% |
| 10-Year ReturnCumulative with dividends | +30.2% | +265.1% | +50.9% | +58.9% |
| CAGR (3Y)Annualised 3-year return | +12.4% | +29.6% | +28.7% | +20.2% |
Risk & Volatility
Evenly matched — SBRA and NHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
NHI is the less volatile stock with a -0.08 beta — it tends to amplify market swings less than NHPAP's 0.17 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SBRA currently trades 97.7% from its 52-week high vs NHI's 82.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.17x | 0.14x | -0.06x | -0.08x |
| 52-Week HighHighest price in past year | $22.17 | $41.72 | $21.07 | $90.94 |
| 52-Week LowLowest price in past year | $13.42 | $27.72 | $17.08 | $68.80 |
| % of 52W HighCurrent price vs 52-week peak | +94.4% | +94.7% | +97.7% | +82.5% |
| RSI (14)Momentum oscillator 0–100 | 60.6 | 54.5 | 54.5 | 28.0 |
| Avg Volume (50D)Average daily shares traded | 9K | 2.5M | 2.1M | 332K |
Analyst Outlook
Evenly matched — CTRE and SBRA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CTRE as "Buy", SBRA as "Hold", NHI as "Hold". Consensus price targets imply 13.8% upside for NHI (target: $85) vs 3.0% for SBRA (target: $21). For income investors, SBRA offers the higher dividend yield at 5.75% vs NHPAP's 2.33%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | — | $42.50 | $21.20 | $85.40 |
| # AnalystsCovering analysts | — | 19 | 29 | 18 |
| Dividend YieldAnnual dividend ÷ price | +2.3% | +3.2% | +5.8% | +4.8% |
| Dividend StreakConsecutive years of raises | 0 | 2 | 0 | 1 |
| Dividend / ShareAnnual DPS | $0.49 | $1.27 | $1.18 | $3.61 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.0% | 0.0% | 0.0% |
CTRE leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NHPAP leads in 1 (Valuation Metrics). 2 tied.
NHPAP vs CTRE vs SBRA vs NHI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NHPAP or CTRE or SBRA or NHI a better buy right now?
For growth investors, CareTrust REIT, Inc.
(CTRE) is the stronger pick with 108. 8% revenue growth year-over-year, versus 2. 3% for National Healthcare Properties, Inc. (NHPAP). National Health Investors, Inc. (NHI) offers the better valuation at 24. 9x trailing P/E (22. 2x forward), making it the more compelling value choice. Analysts rate CareTrust REIT, Inc. (CTRE) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NHPAP or CTRE or SBRA or NHI?
On trailing P/E, National Health Investors, Inc.
(NHI) is the cheapest at 24. 9x versus Sabra Health Care REIT, Inc. at 32. 2x. On forward P/E, National Health Investors, Inc. is actually cheaper at 22. 2x.
03Which is the better long-term investment — NHPAP or CTRE or SBRA or NHI?
Over the past 5 years, CareTrust REIT, Inc.
(CTRE) delivered a total return of +96. 6%, compared to +22. 7% for National Healthcare Properties, Inc. (NHPAP). Over 10 years, the gap is even starker: CTRE returned +265. 1% versus NHPAP's +30. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NHPAP or CTRE or SBRA or NHI?
By beta (market sensitivity over 5 years), National Health Investors, Inc.
(NHI) is the lower-risk stock at -0. 08β versus National Healthcare Properties, Inc. 's 0. 17β — meaning NHPAP is approximately -305% more volatile than NHI relative to the S&P 500. On balance sheet safety, CareTrust REIT, Inc. (CTRE) carries a lower debt/equity ratio of 22% versus 167% for National Healthcare Properties, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NHPAP or CTRE or SBRA or NHI?
By revenue growth (latest reported year), CareTrust REIT, Inc.
(CTRE) is pulling ahead at 108. 8% versus 2. 3% for National Healthcare Properties, Inc. (NHPAP). On earnings-per-share growth, the picture is similar: CareTrust REIT, Inc. grew EPS 96. 3% year-over-year, compared to -136. 5% for National Healthcare Properties, Inc.. Over a 3-year CAGR, CTRE leads at 36. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NHPAP or CTRE or SBRA or NHI?
CareTrust REIT, Inc.
(CTRE) is the more profitable company, earning 67. 3% net margin versus -53. 6% for National Healthcare Properties, Inc. — meaning it keeps 67. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTRE leads at 67. 2% versus -34. 9% for NHPAP. At the gross margin level — before operating expenses — SBRA leads at 65. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NHPAP or CTRE or SBRA or NHI more undervalued right now?
On forward earnings alone, National Health Investors, Inc.
(NHI) trades at 22. 2x forward P/E versus 29. 8x for Sabra Health Care REIT, Inc. — 7. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NHI: 13. 8% to $85. 40.
08Which pays a better dividend — NHPAP or CTRE or SBRA or NHI?
All stocks in this comparison pay dividends.
Sabra Health Care REIT, Inc. (SBRA) offers the highest yield at 5. 8%, versus 2. 3% for National Healthcare Properties, Inc. (NHPAP).
09Is NHPAP or CTRE or SBRA or NHI better for a retirement portfolio?
For long-horizon retirement investors, National Health Investors, Inc.
(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 08), 4. 8% yield). Both have compounded well over 10 years (NHI: +58. 9%, NHPAP: +30. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NHPAP and CTRE and SBRA and NHI?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NHPAP is a small-cap quality compounder stock; CTRE is a small-cap high-growth stock; SBRA is a small-cap income-oriented stock; NHI is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.